Capparis zeylanica L. conjugated TiO2 nanoparticles as bio-enhancers for antimicrobial and chronic wound repair

Exploring the dermal safety of green-synthesized Ag-TiO2 nanocomposites for topical applications

We investigated Ag-TiO2 nanocomposites (NCs) synthesized using leaf extracts of Azadirachta indica and Mangifera indica for topical applications. The Ag-TiO2 NCs were first characterized by their spherical shapes, with sizes ranging from 20-26 nm to 5-6 nm, and a zeta potential value between -27 and -23 mV. DLS analysis revealed average particle sizes of 671 nm and 573 nm for Ag-TiO2 NCs synthesized from A. indica and M. indica, respectively. The MICs of the nanocomposites were determined via dilution in both Gram-positive and Gram-negative bacteria to determine the optimal concentration for dermal applications. The cytotoxicity assay (MTT) of ATN and ATM compounds at MICs of 312.5 μg mL-1, 625 μg mL-1, and 1250 μg mL-1 showed that they were nontoxic to fibroblast cells. Further assessments of acute and subacute dermal safety were conducted on Charles Foster rats with NCs applied at 625 μg mL-1, 3125 μg mL-1, and 6250 μg mL-1 concentrations. Observations were made for any signs of dermal toxicity using behavioural and physical indices. In acute dermal toxicity, the NCs were applied once, and in subacute dermal toxicity, NCs were applied once daily for 28 days and observed for any sign of dermal toxicity using observation indices like behavioural changes, edema scores, and erythema scores. Post-experiment analyses of body weight, serum biochemistry, oxidative stress, and hematological profiles revealed that the nanocomposites exhibited significant antimicrobial activity. Notably, the safety evaluations indicated no adverse changes, suggesting these NCs are well-tolerated for dermal applications and show great promise for future topical applications.

Titanium dioxide nanoparticles: a promising candidate for wound healing applications

Effective wound management and treatment are crucial in clinical practice, yet existing strategies often fall short in fully addressing the complexities of skin wound healing. Recent advancements in tissue engineering have introduced innovative approaches, particularly through the use of nanobiomaterials, to enhance the healing process. In this context, titanium dioxide nanoparticles (TiO2 NPs) have garnered attention due to their excellent biological properties, including antioxidant, anti-inflammatory, and antimicrobial properties. Furthermore, these nanoparticles can be modified to enhance their therapeutic benefits. Scaffolds and dressings containing TiO2 NPs have demonstrated promising outcomes in accelerating wound healing and enhancing tissue regeneration. This review paper covers the wound healing process, the biological properties of TiO2 NPs that make them suitable for promoting wound healing, methods for synthesizing TiO2 NPs, the use of scaffolds and dressings containing TiO2 NPs in wound healing, the application of modified TiO2 NPs in wound healing, and the potential toxicity of TiO2 NPs.

Emerging nanomaterials for novel wound dressings: From metallic nanoparticles and MXene nanosheets to metal-organic frameworks

The growing need for developing reliable and efficient wound dressings has led to recent progress in designing novel materials and formulations for different kinds of wounds caused by traumas, burns, surgeries, and diabetes. In cases of extreme urgency, accelerating wound recovery is of high importance to prevent persistent infection and biofilm formation. The application of nanotechnology in this domain resulted in the creation of distinct nanoplatforms for highly advanced wound-healing therapeutic approaches. Recently developed nanomaterials have been used as antibacterial agents or drug carriers to control wound infection. In the present review, the authors aim to review the recently published research on the effects of incorporating emerging nanomaterials into novel wound dressings and investigate their distinct roles in the wound healing process. It was determined that the metallic nanoparticles (NPs) exhibit antimicrobial and regenerative properties, metal oxide NPs regulate inflammation and promote tissue regeneration, MXene NPs enhance cell adhesion and proliferation, while metal-organic frameworks (MOFs) offer controlled drug delivery capabilities. Further research is required to fully understand the mechanisms and optimize the applications of these NPs in wound healing.

Multifunctional antibacterial hydrogels for chronic wound management

Chronic wounds have gradually evolved into a global health challenge, comprising long-term non-healing wounds, local tissue necrosis, and even amputation in severe cases. Accordingly, chronic wounds place a considerable psychological and economic burden on patients and society. Chronic wounds have multifaceted pathogenesis involving excessive inflammation, insufficient angiogenesis, and elevated reactive oxygen species levels, with bacterial infection playing a crucial role. Hydrogels, renowned for their excellent biocompatibility, moisture retention, swelling properties, and oxygen permeability, have emerged as promising wound repair dressings. However, hydrogels with singular functions fall short of addressing the complex requirements associated with chronic wound healing. Hence, current research emphasises the development of multifunctional antibacterial hydrogels. This article reviews chronic wound characteristics and the properties and classification of antibacterial hydrogels, as well as their potential application in chronic wound management.

Fabrication of chitosan nanocomposites loaded with biosynthetic metallic nanoparticles and their therapeutic investigation

The present research demonstrates the formation of zinc oxide nanoparticles facilitated by Cissus quadrangularis (CQ-ZnONPs) and subsequent synthesis of chitosan-conjugated nanocomposites (CQ-CS/ZnONCs) along with their biological assessment. The biosynthesized nanoparticles and nanocomposites were physicochemically characterized and therapeutically assessed for their antioxidant, antibacterial, and antidiabetic potential. The formation of CQ-ZnONPs and CQ-CS/ZnONCs was preliminarily validated by the change in color and subsequently by UV-visible spectroscopic analysis. The crystalline peaks associated with the CQ-ZnONPs in CQ-CS/ZnONCs were established by XRD analysis. Morphological evaluation of CQ-ZnONPs and CQ-CS/ZnONCs was carried out through FE-SEM and HRTEM studies. The particle size of the CQ-ZnONPs and CQ-CS/ZnONCs was 243.3 nm and 176.6 nm, with a PDI of 0.188 and 0.199, respectively. Nanoparticles and nanocomposites expressed Zeta potential of -15.7 mV and -16.2 mV, respectively. The CQ-ZnONPs and CQ-CS/ZnONCs showed good radical effectiveness with various in-vitro assays. The formulated nanoparticles and nanocomposites displayed significant antibacterial activity against the selected bacterial pathogens. CQ-CS/ZnONCs presented noteworthy α-amylase and α-glucosidase inhibitory effects compared to CQ-ZnONPs with IC50 of 73.66 ± 1.21 μg/mL and 87.59 ± 1.29 μg/mL, respectively. Moreover, the synthesized CQ-CS/ZnONCs demonstrated 98.92 ± 0.39% and 99.58 ± 0.16% wound contraction (at 7 and 14 mg, respectively), significantly (p < 0.05) higher than the standard and CQ-ZnONPs. Thus, the CQ-ZnONPs and CQ-CS/ZnONCs could effectively develop promising drug delivery systems to inhibit pathogens and chronic tissue repair.

Eco synthesized chitosan/zinc oxide nanocomposites as the next generation of nano-delivery for antibacterial, antioxidant, antidiabetic potential, and chronic wound repair

The present research work aimed at synthesizing chitosan-coated Zinc oxide nanocomposites (NS-CS/ZnONCs) by a bio-inspired method using an aqueous extract of Nigella sativa (NS) seeds and employing a quality-by-design approach (Box-Behnken design). The biosynthesized NS-CS/ZnONCs were physicochemically characterized and subjected to their in-vitro and in-vivo therapeutic potential. The zeta potential value of -11.2 mV and -12.6 mV indicated the stability of NS-mediated synthesized zinc oxide nanoparticles (NS-ZnONPs) and NS-CS/ZnONCs, respectively. The particle size of NS-ZnONPs and NS-CS/ZnONCs were 288.1 nm and 130.2 nm, respectively, with PDI of 0.198 and 0.158. NS-ZnONPs and NS-CS/ZnONCs showed superior radical scavenging abilities, excellent α-amylase, and α-glucosidase inhibitory activities. Also, NS-ZnONPs and NS-CS/ZnONCs demonstrated effective antibacterial activity against selected pathogens. Furthermore, NS-ZnONPs and NS-CS/ZnONCs demonstrated significant (p < 0.001) wound closure with 93.00 ± 0.43 % and 95.67 ± 0.43 % on the 15th day of treatment at the dose of 14 mg/wound, compared to 93.42 ± 0.58 % of standard. Collagen turnover was represented by hydroxyproline, which was shown to be significantly (p < 0.001) higher in the NS-ZnONPs (60.70 ± 1.44 mg/g of tissue) and NS-CS/ZnONCs (66.10 ± 1.23 mg/g of tissue) treatment groups than in the control group (47.7 ± 0.81 mg/g of tissue). Thus the NS-ZnONPs and NS-CS/ZnONCs could effectively develop promising drugs to inhibit pathogens and chronic tissue repair.